TRIP4 is a conserved transcriptional coactivator that is involved in the regulation of the expression of multiple genes. It consists of a classical N-terminal C2HC5-like zinc-finger domain and a conserved C-terminal ASCH domain. Here, we characterized the DNA-binding properties of the human TRIP4 ASCH domain. Our biochemical data show that TRIP4-ASCH has comparable binding affinities toward ssDNA and dsDNA of different lengths, sequences, and structures. The crystal structures reveal that TRIP4-ASCH binds to DNA substrates in a sequence-independent manner through two adjacent positively charged surface patches: one binds to the 5'-end of DNA, and the other binds to the 3'-end of DNA. Further mutagenesis experiments and binding assays confirm the functional roles of key residues involved in DNA binding. In summary, our data demonstrate that TRIP4-ASCH binds to the 5' and 3'-ends of DNA in a sequence-independent manner, which will facilitate further studies of the biological function of TRIP4.
Keyphrases
- dna binding
- transcription factor
- circulating tumor
- cell free
- single molecule
- endothelial cells
- genome wide identification
- electronic health record
- genome wide
- gene expression
- nucleic acid
- induced pluripotent stem cells
- high throughput
- high resolution
- machine learning
- circulating tumor cells
- deep learning
- dna methylation
- oxidative stress
- mass spectrometry
- genetic diversity